Skip to main content

Coles N Anthony's Form 4 filing

Cerevel Therapeutics Holdings, Inc. (CERE) · filed Feb 8, 2023

Accession no.
0000899243-23-004360
Filed
Feb 8, 2023
Trade date
Feb 6-7, 2023
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 3 non-derivative transactions and 3 derivative transactions. Open-market sales total $1.66M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Coles N AnthonyCIK 0001197018Director, Officer (CEO and Chairperson)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 7, 2023Common StockMOption exerciseAcquired+50,000$3.50+$175,00052,704Direct
Feb 7, 2023Common StockSSaleDisposed−42,058$33.04−$1,389,596.3210,646Direct
Feb 7, 2023Common StockSSaleDisposed−7,942$33.57−$266,612.942,704Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Feb 6, 2023Common StockAGrant or awardAcquired+243,042$0.00$0243,042Direct
Feb 6, 2023Common StockAGrant or awardAcquired+61,762$0.00$061,762Direct
Feb 7, 2023Common StockMOption exerciseDisposed−50,000$0.00$02,952,417Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)